Event Highlights

Here is a summary of everything you need to know about our summit

Topic Highlights

  • Divergences and Harmonization in Risk Minimization and Global Pharmacovigilance.
  • Signal Detection and Evaluation.
  • Recent Trends in Drug Safety: The Growing and Evolving Role of Real-World Evidence.
  • Artificial Intelligence and Machine Learning Use in Patient Safety.
  • PV Regulatory Updates: Global Landscape.
  • Risk Communication in Pharmacovigilance: Lookouts, Challenges, and Strategies.
  • PV Inspections and Audit: Regulatory Aspects in Pharmacovigilance.
  • Digital Health Technology and PV.

A methodical strategy to recognise, evaluate, comprehend, respond to, and articulate medication safety and risk issues. Drug safety and risk management have evolved over the last centuries, and there have been several tragedies to learn from to protect patients. As with any medication, there are risks associated with its use, including the possibility of adverse reactions, interactions with other medications, and the risk that the product may not function as effectively as anticipated. Pronovea is bringing together pharmacovigilance pioneers and healthcare innovators to discuss and exchange best practices and strategic insights and to collaborate to enhance drug safety and risk management.

Network With

GMs, C-level, Senior Vice Presidents, Directors, Head of Departments, Managers,Scientific Advisors from Pharma Industry involved in:
  • Pharmacovigilance
  • Risk Management Planning
  • PV Collaborations
  • Drug Monitoring
  • Regional & Global Patient Safety
  • QPPVs
  • Medical Affairs
  • Clinical Safety
  • Clinical Research
  • Global PV Operations Safety
  • Scientific Affairs
  • Drug Safety
  • Safety Surveillance
  • Safety Officer
  • Signal Detection Management
  • Innovations and Digitalisation
  • Global R&D
  • Collection Compliance
  • REMS
  • Medical Product SafetyAssessment